Main Session
Sep
28
QP 07 - Predicting, Protecting, Preserving, and Pushing Dose in Rectal Cancer
1039 - CXCL12-Driven Anti-Tumor Neutrophil Infiltration Predicts Pathological Complete Response in pMMR Rectal Cancer Treated with Neoadjuvant SCRT and PD-1 Blockade
Presenter(s)
Meng He, MD, PhD - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Guangdong